Study to Evaluate the ECG Effects of Telaglenastat in Healthy Adult Subjects
Clinical trial NCT04607512 · COMPLETED
Trial details
- NCT number
- NCT04607512
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2020-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.